Introduction
============

Mesenchymal stem cells (MSCs), also referred to as multipotent mesenchymal stromal cells, are present in all the organs throughout the body and play a key role in tissue regeneration. Aside from their ability to orchestrate regeneration processes, MSCs are newly proposed as critical players in host defence and inflammation [@b1].

Under physiological conditions, the oral cavity, gastrointestinal tract and skin home complex ecosystems of commensal bacteria that live in a mutually beneficial state with the host. In case of tissue injury or inflammatory diseases, stem cells are mobilized towards the site of damage, thus coming to close vicinity of bacteria and bacterial components. Bacterial infection of stem cells could even lead to long-term functional consequences for the host [@b2]. Recent reports suggest that MSCs may be able to actively participate in the control of infectious challenges by direct targeting of bacteria and through indirect effects on the host primary and adaptive immune response [@b3].

Oral microflora
===============

The oral cavity, like the skin, the respiratory tract and the gut, is habitat to a plethora of microbiota living in symbiosis with the host [@b4]. The oral microflora is known to contain over 700 species of aerobic and anaerobic bacteria [@b5]. These organisms can be isolated from tooth surfaces, periodontal pockets and other oral sites such as the tongue and oral mucous membranes [@b6]. Oral microbiota grow as complex, mixed, interdependent colonies organized in biofilms [@b7]. Reports in the literature suggest that oral bacterial biofilms may contain more than 10^5^ microorganisms [@b8], while the concentrations and compositions of pathogenic bacteria in the subgingival biofilm vary greatly depending on the local microenvironmental conditions [@b9],[@b10]. The bacterial genera which are mostly represented in the oral cavity include the following: *Gemella*, *Granulicatella*, *Streptococcus*, *Veillonella*, *Neisseria*, *Haemophilus*, *Rothia*, *Actinomyces*, *Prevotella*, *Capnocytophaga*, *Porphyromona*, *Fusobacterium*, *Corynebacterium*, *Cardiobacterium*, *Campylobacter*, *Corynebacterium*, *Atopobium* and *Bergeyella* [@b11]--[@b13]. It should be noticed that almost 60% of the species detected by new molecular methods are not presently cultivable and remain uncharacterized [@b11].

The natural oral microflora is vital for the normal development and physiological integrity of the oral cavity. It also contributes to host defence by excluding exogenous microorganisms [@b14]. It is widely recognized that the maintenance of an ecologically balanced biodiversity of the microflora within the oral cavity is crucial not only to the oral health but also to the general health of the host [@b15]. Microbes have commensal relationships with their co-habitants, while being symbiotic with their host [@b16]. However, ecological shifts may lead to pathological conditions, which alter the relationships between microbes and the host [@b17]. In disease, pathogenic bacteria grow with disregard to their co-habitant bacteria and express their virulence properties, so that the host becomes infected or susceptible to infection [@b16].

Periodontitis
=============

Periodontitis is a bacterially induced inflammatory disease of the supporting tissues of the teeth. It represents one of the major dental diseases that affect human populations worldwide at high prevalence rates and has a huge economic impact on national health care systems [@b18]. In fact, periodontitis is characterized by progressive periodontal tissue destruction that may finally lead to the loosening and subsequent loss of teeth [@b19]. The predominant pathogens involved in periodontitis are *Aggregatibacter actinomycetemcomitans*, *Porphyromonas gingivalis*, *Prevotella intermedia*, *Fusobacterium nucleatum*, *Tannerella forsythia*, and *Eikenella corrodens*, and *Treponema denticola* [@b15].In addition, several forms of uncultivable spirochetes are supposed to play a major role in the pathogenesis of this disease [@b20].

Periodontal pathogens induce tissue destruction by activating the host defence. The infection of periodontal tissues is accompanied by the release of bacterial leucotoxins, collagenases, fibrinolysins and other proteases that break down host tissues and may result in gingival inflammation [@b21]. Specifically, microbial components, like lipopolysaccharide (LPS), have the capacity to activate macrophages and lymphocytes to synthesize and secrete a wide array of molecules including cytokines, prostaglandins, hydrolytic enzymes and tumour necrosis factor alpha, which in turn stimulate the effectors of periodontal tissue breakdown [@b22]. Cell activation occurs mainly through two members of the Toll-like receptor (TLR) family, TLR2 and TLR4 that are documented as predominant signalling receptors for most bacterial components [@b23],[@b24].

Once a periodontal pocket forms and becomes colonized by bacteria, the pathologic situation becomes irreversible [@b18]. The conventional periodontal treatment involves the mechanical removal of the pathogenic dental biofilm. Successful clinical outcomes such as probing depth reduction and gain of clinical attachment after treatment are well documented in a plethora of studies [@b25]--[@b27]. However, histological analyses of healed periodontal tissues reveal in most of the cases the presence of an epithelial lining along the treated root surfaces of the teeth, instead of true periodontal regeneration [@b28].

Dental stem cells
=================

Stem cells are defined by their capacity to self-renew and differentiate into multiple cell lineages. One of the most studied adult stem cell types are MSCs [@b29]. Friedenstein *et al*. first described bone marrow stem cells (BMSCs) as a heterogeneous population of multipotent cells derived from bone marrow aspirates with the ability to adhere to plastic surfaces and form colonies of fibroblast-like cells within the first days of cultivation [@b30],[@b31]. Although MSCs were originally isolated from the bone marrow, similar populations of mesenchymal precursors were isolated from other tissues, including adipose tissue [@b32], amniotic fluid [@b33], foetal liver [@b34] and umbilical cord blood (UCB) [@b35].

During the last decades, rapid progress in dental research has shed light on the molecular and cellular biology of periodontal tissue development. Recently, multipotent cells have been successfully isolated from several dental tissues including dental pulp [@b36], dental follicle [@b37], exfoliated deciduous teeth [@b38] and the root apical papilla [@b39]. Several *in vitro* and *in vivo* studies on dental stem cells (DSCs) provide evidence of their multipotent character and their key role in periodontal regeneration [@b40]. It has been demonstrated that DSCs have a fibroblast-like morphology and are plastic-adherent. Similar to other stem cell populations, DSCs express several surface markers such as CD10, CD13, CD29, CD44, CD53, CD59, CD73, CD90 and CD105, and do not express CD34, CD45 or HLA-DR [@b41],[@b42]. Demonstration of self-renewal ability and multilineage differentiation capacity are additional indications of their stem cell phenotype. Indeed, it has been proven that DSCs are able to form single cell-derived colonies and differentiate into several lineages, when induced by special media *in vitro* [@b43].

Clinical relevance
==================

The identification of DSCs has stimulated interest in the potential use of cell-based therapies as prospective alternatives to existing therapeutic approaches for the repair and regeneration of the periodontium [@b44]. One of the critical requirements for the success of such therapeutic interventions would be the repopulation of the periodontal wound by *ex vivo* expanded progenitor populations or the mobilization of endogenous progenitor cells capable of promoting regeneration [@b45]. Specifically, DSCs grafts may support the restoration of the complex ultrastructure of the periodontal ligament and the dynamic functional relationships of its components. Numerous animal studies have already proved the regenerative potency of these cell populations *in vivo* [@b46].

However, one of the growing concerns in dental research is the exposure of DSCs to the inflamed microenvironment of periodontal pockets [@b47]. This may affect many cell properties such as self-renewal, differentiation potential, production of cytokines and extracellular matrix compounds secretion. Sorrell and Caplan demonstrated that multipotent cell grafts might trigger regenerative processes not only through direct commitment, but also by infiltrating inflammatory or antigen-presenting cells [@b48]. Such a regenerative microenvironment may impel self-regulated regenerative cascades and limit the area of damage in the inflamed adult tissues [@b49]. Hence, a better understanding of cell behaviour at sites of bacterial infection appears to be a key strategy for the development of new approaches for periodontal regeneration.

*In vitro* experimental models
==============================

The microenvironment of a periodontal pocket is characterized by the constant presence of bacterial biofilms. This condition results in a continuous cross-talk of periodontal tissue cells with a wide variety of oral microorganisms. Further, in periodontitis, several types of host immune cells (*e.g*. neutrophils and macrophages) migrate to the site of inflammation [@b50]. The better understanding of the complex cell--bacteria interactions is essential for the development of successful periodontal therapies. While several *in vivo* models have been already used, the design of an *in vitro* model that could sufficiently mimic the *in vivo* situation of inflamed periodontal tissues remains to be developed [@b51].

Till now most of the *in vitro* experimental settings are based on the analysis of the LPS effects on cells. Lipopolysaccharide is a major membrane component of Gram-negative bacteria and can be derived from several bacterial species, *e.g. Escherichia coli* or *P. gingivalis* [@b47],[@b52],[@b53]. The easy isolation method and the fact that LPS is responsible for many of the inflammatory responses and pathogenic effects of Gram-negative bacteria are the main arguments for the use of LPS in numerous *in vitro* experiments. Experimental settings using heat-inactivated or sonicated bacteria have also been proposed as models that may correspond to the *in vivo* condition of bacterial infection [@b54],[@b55]. Further methods used for the analysis of cell--bacteria interactions are based on the fact that periopathogenic bacterial pathogens produce a broad array of potential virulence factors apart from LPS that are released into the gingival crevicular fluid [@b56]. Thus, the culture of cells with bacterial pre-conditioned medium or the co-cultivation of cells and bacteria in transwell systems have been used to evaluate the secretion of soluble factors and the activation of cellular downstream cascades by bacteria [@b57],[@b58]. Although many biological effects can be elicited by non-viable bacteria, it is known that some cell responses require the presence of live bacteria [@b59].

Experimental models utilizing microorganisms in a planktonic state were used to imitate the periodontal infection [@b60]. Nevertheless, such systems may not adequately portray the bacterial challenge conferred by a polymicrobial, biofilm-induced disease, such as periodontitis [@b61]. Thus, *in vitro* multispecies dental biofilm settings have been proposed as laboratory models that better mimic the environment of chronic periodontitis [@b62]--[@b64]. Finally, cell invasion is a common strategy of pathogens that facilitates their escape from host immune system, access to nutrients, persistence and spread into tissues [@b65]. Recent studies using viable bacteria have been demonstrated as models for the analysis of host cell invasion processes such as bacterial adherence and internalization by cells [@b66],[@b67]. However, the subgingival bacteria that are closely correlated with periodontitis are mainly anaerobes. The co-culture of these bacteria with oxygen-requiring cells in conventional systems is not possible [@b68]. Therefore, one weak point of the experimental studies on periodontal infection is the fact that most *in vitro* settings are conducted under aerated conditions. Given the fact that aerotolerance of strictly anaerobic pathogens like *P. gingivalis* is very low, the interpretation of such experimental results may not directly reflect the *in vivo* situation [@b69]. Until now only few models have been proposed utilizing direct contact between live obligate anaerobic bacteria and human cell lines under oxygen-free conditions [@b70],[@b71].

Influence of oral bacteria on stem cells
========================================

Effects on cell viability and proliferation of stem cells
---------------------------------------------------------

Cell proliferation is fundamental in tissue homoeostasis and can be controlled by either physiological or pathological conditions. Previous studies have demonstrated that LPS derived from periopathogenic bacteria may induce controversial effects on the proliferation of periodontal ligament fibroblasts [@b72]--[@b74]. Currently, the possible effect of bacteria on the proliferative rates of multipotent cells is in the focus of interest of several research groups. Kato *et al*. demonstrated that *P. gingivalis* LPS promoted cell proliferation in periodontal ligament stem cells (PDLSCs) [@b53]. Stimulation of TLR2 also led to enhanced proliferation of adult BMSCs [@b75]. Further, Jiang *et al*. and Buchon *et al*. proposed that intestinal stem cells are able to maintain tissue homoeostasis by increasing their proliferation rates to repair tissue damage at sites of infection through the JAK-STAT signalling pathway [@b76],[@b77].

On the contrary, according to an *in vitro* study on canine adipose-derived MSCs (ADSCs), gastrointestinal microbes did not induce cell death nor diminished cell proliferation. Previous studies on dental follicle progenitors also demonstrated that cell viability of both dental follicle progenitor cells (DFPCs) and BMSCs was not affected by *P. gingivalis* LPS treatment [@b47],[@b78]. In addition, TLR ligands such as LPS and flagellin do not alter proliferation rates of a newly identified population of pluripotent UCB cells, which are termed as unrestricted somatic stem cells [@b79]. Nevertheless, LPS and extracts from *Streptococcus mutans* treatment were able to inhibit the proliferation of dental pulp stem cells (DPSCs) *in vitro* [@b80].

These heterogeneous effects of bacteria on the induction or inhibition of cell proliferation across studies could imply the complexity of the underlying mechanisms that rule the interactions between host cells and bacteria. Specifically, cell response to bacterial stimuli seems to be associated with the cell type, bacterial strain and specific bacterial components used in each experimental setting [@b81].

Effects on differentiation capacity of stem cells
-------------------------------------------------

The ability of stem cells to differentiate into multiple lineages is well documented. Especially the differentiation capacity of DSCs across the osteogenic, chondrogenic, adipogenic and neurogenic lineages has been demonstrated from several research groups in the last years [@b82],[@b83]. Nevertheless, the impact of bacteria on the differentiation capacity of stem cells remains to be explored. In a recent study, Ronay *et al*. demonstrated that infected periodontal granulation tissues harbour cells expressing embryonic stem cell markers, and exhibit osteogenic capacities [@b84]. These results are in accordance with other studies demonstrating elevated alkaline phosphatase (ALP) activity, an early marker for osteogenic differentiation, and calcium deposition after *E. coli* LPS treatment of BMSCs [@b52].

Nevertheless, an increased ALP activity after LPS treatment may not always lead to formation of mineralized nodules *in vitro*. It is suggested that LPS may partly block the progression of molecular processes involved in osteogenic differentiation [@b47]. Interestingly, Abe *et al*. demonstrated that low concentrations of *P. gingivalis* extracts improve the osteogenic differentiation of human dental pulp-derived cells while high concentrations may inhibit ALP activity and bone sialoprotein gene expression [@b85]. High concentration of sodium butyrate, a major metabolic by-product of anaerobic Gram-negative periodontopathogenic bacteria, could inhibit the osteoblastic differentiation and mineralized nodule formation in an osteoblastic cell line *in vitro* [@b86]. In accordance with these results *P. gingivalis* LPS was shown to suppress the osteoblastic differentiation in both PDLSCs and DFPCs [@b47],[@b53]. Nomiyama *et al*. suggested that Gram-negative bacterial infection might down-regulate the odontoblastic properties of rat pulp progenitor cells after stimulation with *A. actinomycetemcomitans* LPS [@b87]. Treatment with LPS from *P. gingivalis* was shown to impair both ALP activity and the formation of mineral deposits in DPSCs [@b88]. In this context, TLR ligands have been proposed as possible regulators of stem cell differentiation state *in vitro* [@b78].

Further, *P. gingivalis* fimbriae are proposed as potent inducers of a monocyte/macrophage tumour cell line differentiation, *via* cyclic nucleotide-independent protein kinase C [@b89]. However, *P. gingivalis* fimbriae were proved unable to alter the osteoblastic differentiation and mineralization in long-term mouse calvarial osteoblast cultures [@b90].

Effects on the immunomodulatory properties of stem cells
--------------------------------------------------------

In the last years the immunomodulatory functions of the stem cells have been in the focus of research [@b91]. Accumulating evidence indicated that MSCs may affect neighbouring innate and adaptive immune cells by two main ways: the direct cell--cell contact and the release of a variety of soluble factors [@b92]--[@b97]. Gingiva-derived MSCs (GMSCs) were shown to have immunomodulatory functions. Specifically, GMSCs were able to suppress peripheral blood lymphocyte proliferation and induce expression of a wide panel of immunosuppressive factors including interleukin (IL)-10, indoleamine 2,3-dioxygenase, inducible nitric oxide synthase and cyclooxygenase 2 in response to the inflammatory cytokine, interferon-γ [@b98]. However, the behaviour of cells under the direct influence of bacteria remains less understood.

Reed *et al*. recently demonstrated that human embryonic stem cell-derived endothelial cells (hESC-ECs) are TLR4 deficient but respond to bacteria *via* the intracellular receptor nucleotide-binding oligomerization domain-containing protein 1 (NOD1). The authors suggested that hESC-ECs may be protected from unwanted TLR4-mediated vascular inflammation, thus offering a potential therapeutic advantage [@b99]. On the other side, studies on DFPCs revealed the expression of TLR2 and TLR4 in both mRNA and protein level. Nevertheless, when these cells were treated with *P. gingivalis* LPS no effect on the expression of pro-inflammatory cytokines has been observed [@b47],[@b78]. Further, treatment with TLR4 agonist augmented the suppressive potential of DFPCs and increased the transforming growth factor-beta production [@b100]. In accordance with these results canine ADSCs were shown to enhance immunomodulation after interacting with gastrointestinal microbes *in vitro* [@b101].

It is reported that LPS is able to induce the expression of the nuclear factor κB (NF-κB) -dependent gene IL-8 by DPSCs [@b102]. He *et al*. suggested that LPS-mediated transcriptional and post-translational up-regulation of IL-8 in DPSCs is a process that also involves TLR4, myeloid differentiation primary response gene 88 (MyD88), NF-κB and mitogen-activated protein kinases [@b103]. Further, Mei *et al*. demonstrated that MSCs improve the survival of sepsis by the down-regulation of inflammation-related genes (such e.g. IL-10 and IL-6) and a shift towards the up-regulation of genes involved in promoting phagocytosis and bacterial killing [@b104]. The direct interaction of MSCs with the oral bacteria *F. nucleatum* and *P. gingivalis* led to a lower secretion of IL-8 compared to a differentiated tumour cell line [@b66]. Raffaghello *et al*. support the immunomodulatory function of MSCs showing the inhibition of neutrophil apoptosis because of the secretion of IL-6 by MSCs [@b105]. Nevertheless, these results should be interpreted carefully as it is speculated that the cytokine induction profile of stem cells is dependent on the cell type, bacterial species and methodology used (*e.g*. period of stimulation) [@b79],[@b106].

Current challenges and future perspectives
==========================================

The rapid advancements in the field of dental research over the last few years could realize the promise of tissue regeneration through stem cells. Specifically, the demand for novel therapies against inflammatory diseases, like periodontitis, has created the need for a better understanding of the behaviour of the multipotent cells at sites of infection. Stem cells are supposed to support tissue homoeostasis by providing soluble factors, transdifferentiation or cell fusion [@b107]. Hence, studies demonstrating stem cell responsiveness to bacteria raise questions on the possible contribution of multipotent cells to both tissue regeneration and outbreak of inflammation. Selected reports on the impact of bacteria on stem cells are listed in Table[1](#tbl1){ref-type="table"}.

###### 

Selected reports on the impact of bacteria on stem cells

  Biological impact   Cell populations                                              Bacterial species                         Experimental model   Reference
  ------------------- ------------------------------------------------------------- ----------------------------------------- -------------------- -----------
  Cell viability      DFPCs                                                         *P. gingivalis*                           Treatment with LPS   [@b47]
  PDLSCs              *P. gingivalis*                                               Treatment with LPS                        [@b53]               
  DFPCs, BMSCs        *P. gingivalis*                                               Treatment with LPS                        [@b78]               
  USSCs               Undefined                                                     Treatment with LPS and flagellin          [@b79]               
  DPSCs               *S. mutans*                                                   Treatment with LPS                        [@b80]               
  Differentiation     DFPCs                                                         *P. gingivalis*                           Treatment with LPS   [@b47]
  BMSCs               *E. coli*                                                     Treatment with LPS                        [@b52]               
  PDLSCs              *P. gingivalis*                                               Treatment with LPS                        [@b53]               
  USSCs               Undefined                                                     Treatment with LPS and flagellin          [@b79]               
  DPPCs               *A.actinomyce-temcomitans*                                    Treatment with LPS                        [@b87]               
  DPSCs               *P. gingivalis*                                               Treatment with LPS                        [@b88]               
  Immunomodulation    DFPCs                                                         *P. gingivalis*                           Treatment with LPS   [@b47]
  BMSCs               *P. gingivalis*, *F. nucleatum*, *A.actinomyce-temcomitans*   Co-culture model                          [@b69]               
  DFPCs, BMSCs        *P. gingivalis*, *F. nucleatum*                               Co-culture model                          [@b70]               
  DFPCs, BMSCs        *P. gingivalis*                                               Treatment with LPS                        [@b78]               
  USSCs               Undefined                                                     Treatment with LPS and flagellin          [@b79]               
  ESC-ECs             Undefined                                                     Treatment with LPS and *C12*-*iE*-*DAP*   [@b99]               
  DFSCs, DPSCs        Undefined                                                     Treatment with LPS                        [@b100]              
  AMSCs               *S. typhimurium*, *L. acidophilus*                            Co-culture model                          [@b101]              
  DPSCs               *P. gingivalis*, *E. coli*, *P. endodontalis*                 Treatment with LPS                        [@b102]              
  DPSCs               Undefined                                                     Treatment with LPS                        [@b103]              
  MSCs                Undefined                                                     Polymicrobial model of sepsis             [@b104]              

Stem cells: AMSCs, adipose-derived mesenchymal stem cells; BMSCs, bone marrow stem cells; DFPCs, dental follicle progenitors cells; DPPCs, dental pulp progenitor cells; DPSCs, dental pulp stem cells; ESC-ECs, human embryonic stem cell-derived endothelial cells; MSCs, mesenchymal stem cells; PDLSCs, periodontal ligament stem cells; USSCs, unrestricted somatic stem cells. Bacteria: *A. actinomycetemcomitans*, *Aggregatibacter actinomycetemcomitans*; *E. coli*, *Escherichia coli*; *F. Prausnitzii*, *Faecalibacterium prausnitzii*; *L. acidophilus*, *Lactobacillus acidophilus*; *P. endodontalis*, *Porphyromonas endodontalis*; *P. gingivalis*, *Porphyromonas gingivalis*; *S. mutans*, *Streptococcus mutans*; *S. typhimurium*, *Salmonella typhimurium*.

The notion that bacteria may stimulate and drive the regenerative potential of stem cells should be further explored. Till now, data from *in vitro* studies utilizing single populations of cells challenged with bacterial components or mono-infections of planktonic bacteria may not adequately portray human periodontal diseases. Another significant parameter, which should be taken into consideration, is the oxygen concentration of *in vitro* models, as most of the pathogenic species implicated in the pathogenesis of periodontitis are obligate anaerobes. It is also remarkable that only few studies have used PDLSCs, which are the main population of multipotent cells residing within the periodontium. Thus, the development of new experimental settings to better resemble the *in vivo* periodontal milieu seems to be crucial.

A better understanding of the beneficial effects of bacteria on stem cells may allow future interventions based on cell priming with bacterial components prior to transplantation in sites of tissue destruction. Even the colonization of inflamed tissues with specific bacterial species that promote the mobilization of tissue-resident multipotent cell populations could be part of new therapeutic approaches. On the other side, the extent of stem cells' involvement in immunomodulation remains to be clarified. Both immunosuppression and stimulation of host immune responses regulated by stem cells could be used as advanced tools against bacterially induced inflammation. In conclusion, the identification of intracellular signalling pathways regulating multipotency and immunomodulation of stem cells being exposed to bacteria may enable the development of successful therapeutic interventions in inflammatory diseases.
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